Serum interleukin-2 and interleukin-6 levels in iron deficiency anemia

Area of Science:

• Pediatric Hematology
• Immunology
• Nutritional Science

Background:

• Iron deficiency anemia (IDA) is a prevalent condition in children, impacting various physiological systems.
• The role of specific cytokines, such as interleukin-2 (IL-2) and interleukin-6 (IL-6), in IDA pathophysiology requires further elucidation.
• Understanding immune system alterations in IDA is crucial for targeted therapeutic interventions.

Purpose of the Study:

• To investigate serum levels of IL-2 and IL-6 in pediatric patients diagnosed with IDA.
• To assess the impact of iron supplementation on IL-2 and IL-6 serum concentrations in children with IDA.
• To compare cytokine profiles between children with IDA and healthy controls.

Main Methods:

• A cohort of 25 children (6 months to 3 years) with IDA was enrolled.
• A control group of 10 age- and sex-matched healthy children was included for comparison.
• Serum levels of IL-2 and IL-6 were measured before and after a course of iron supplementation in the IDA group.

Main Results:

• Children with IDA exhibited significantly lower serum IL-2 levels compared to healthy controls (P < .001).
• Following iron supplementation, IL-2 levels in the IDA group normalized to those observed in controls.
• Serum IL-6 levels did not show a significant difference between children with IDA and controls, nor did they change after iron supplementation (P > .05).

Conclusions:

• Iron deficiency anemia in children is associated with impaired IL-2 production.
• Iron supplementation effectively restores normal IL-2 levels in children with IDA.
• Serum IL-6 levels appear unaffected by iron deficiency or supplementation in this pediatric population.